← Leaderboards
Huamin Wang
University Of Tx Md Anderson Can Ctr
$4,120,166
Attributed
$4,120,166
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $732K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,120,166 · 5
By mechanism
R01$2,906,039 · 2
P01$836,112 · 2
R21$378,015 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ronald Anthony Depinho$97,148,322
- Peter W Pisters$146,474
- Anil K Sood$29,572,737
- Michael W Andreeff$17,991,896
- Vahid Afshar-Kharghan$3,543,397
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularSignal PathwayMalignant NeoplasmsPlayMediatingRegulationMalignant Neoplasm Of PancreasPathway InteractionsPancreatic DuctPancreatic Intraepithelial NeoplasiaOverexpressionMolecular TargetTherapeutic InterventionPhenotypeCollectionPancreasTumorGeneticResourcesValidationMutationMouse ModelPublic Health RelevanceLead
Grant awards (16)
Core A-Pathology Core$148,529
P01 · FY2025 · CA · contact PI
Core A-Pathology Core$166,209
P01 · FY2024 · CA · contact PI
Core A-Pathology Core$174,957
P01 · FY2023 · CA · contact PI
Core A-Pathology Core$171,459
P01 · FY2022 · CA · contact PI
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation$240,400
R01 · FY2021 · CA · contact PI
Core A-Pathology Core$174,958
P01 · FY2021 · CA · contact PI
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis$366,000
R01 · FY2020 · CA · contact PI
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation$366,000
R01 · FY2020 · CA · contact PI
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis$355,019
R01 · FY2019 · CA · contact PI
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation$114,620
R01 · FY2019 · CA · contact PI
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis$366,000
R01 · FY2018 · CA · contact PI
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation$366,000
R01 · FY2017 · CA · contact PI
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis$366,000
R01 · FY2017 · CA · contact PI
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis$366,000
R01 · FY2016 · CA · contact PI
Proteasome-mediated Degradation of Hematopoietic Progenitor Kinase 1 in Pancreati$171,825
R21 · FY2012 · CA · contact PI
Proteasome-mediated Degradation of Hematopoietic Progenitor Kinase 1 in Pancreati$206,190
R21 · FY2011 · CA · contact PI